EWSR1 and Ewing sarcoma: We also investigated a pharmacological inhibitor of EWS (mithramycin) in combination with TFL and found that mithramycin was not as useful as the genetic inhibitor (EWS shRNA plasmid) in reducing the cell viability in human Ewing’s sarcoma cells.